Hip Resurfacing Arthroplasty and Perioperative Blood Testing
It is standard practice in many institutions to routinely perform preoperative and postoperative haemoglobin level testing in association with hip joint arthroplasty procedures. It is our observation, however, that blood transfusion after uncomplicated primary hip arthroplasty in healthy patients is...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Advances in Orthopedics |
Online Access: | http://dx.doi.org/10.1155/2014/109378 |
id |
doaj-23406d9a9490428a88b56999ee8f43da |
---|---|
record_format |
Article |
spelling |
doaj-23406d9a9490428a88b56999ee8f43da2020-11-24T22:07:44ZengHindawi LimitedAdvances in Orthopedics2090-34642090-34722014-01-01201410.1155/2014/109378109378Hip Resurfacing Arthroplasty and Perioperative Blood TestingAndrew Cook0Steven Cook1Ian Smith2Patrick Weinrauch3Toowoomba Base Hospital, QLD, AustraliaSt. Andrew’s War Memorial Hospital, 457 Wickham Terrace, Spring Hill, QLD, AustraliaSt. Andrew’s Medical Institute, QLD, AustraliaSt. Andrew’s War Memorial Hospital, 457 Wickham Terrace, Spring Hill, QLD, AustraliaIt is standard practice in many institutions to routinely perform preoperative and postoperative haemoglobin level testing in association with hip joint arthroplasty procedures. It is our observation, however, that blood transfusion after uncomplicated primary hip arthroplasty in healthy patients is uncommon and that the decision to proceed with blood transfusion is typically made on clinical grounds. We therefore question the necessity and clinical value of routine perioperative blood testing about the time of hip resurfacing arthroplasty. We present analysis of perioperative blood tests and transfusion rates in 107 patients undertaking unilateral hybrid hip resurfacing arthroplasty by the senior author at a single institution over a three-year period. We conclude that routine perioperative testing of haemoglobin levels for hip resurfacing arthroplasty procedures does not assist in clinical management. We recommend that postoperative blood testing only be considered should the patient demonstrate clinical signs of symptomatic anaemia or if particular clinical circumstances necessitate.http://dx.doi.org/10.1155/2014/109378 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrew Cook Steven Cook Ian Smith Patrick Weinrauch |
spellingShingle |
Andrew Cook Steven Cook Ian Smith Patrick Weinrauch Hip Resurfacing Arthroplasty and Perioperative Blood Testing Advances in Orthopedics |
author_facet |
Andrew Cook Steven Cook Ian Smith Patrick Weinrauch |
author_sort |
Andrew Cook |
title |
Hip Resurfacing Arthroplasty and Perioperative Blood Testing |
title_short |
Hip Resurfacing Arthroplasty and Perioperative Blood Testing |
title_full |
Hip Resurfacing Arthroplasty and Perioperative Blood Testing |
title_fullStr |
Hip Resurfacing Arthroplasty and Perioperative Blood Testing |
title_full_unstemmed |
Hip Resurfacing Arthroplasty and Perioperative Blood Testing |
title_sort |
hip resurfacing arthroplasty and perioperative blood testing |
publisher |
Hindawi Limited |
series |
Advances in Orthopedics |
issn |
2090-3464 2090-3472 |
publishDate |
2014-01-01 |
description |
It is standard practice in many institutions to routinely perform preoperative and postoperative haemoglobin level testing in association with hip joint arthroplasty procedures. It is our observation, however, that blood transfusion after uncomplicated primary hip arthroplasty in healthy patients is uncommon and that the decision to proceed with blood transfusion is typically made on clinical grounds. We therefore question the necessity and clinical value of routine perioperative blood testing about the time of hip resurfacing arthroplasty. We present analysis of perioperative blood tests and transfusion rates in 107 patients undertaking unilateral hybrid hip resurfacing arthroplasty by the senior author at a single institution over a three-year period. We conclude that routine perioperative testing of haemoglobin levels for hip resurfacing arthroplasty procedures does not assist in clinical management. We recommend that postoperative blood testing only be considered should the patient demonstrate clinical signs of symptomatic anaemia or if particular clinical circumstances necessitate. |
url |
http://dx.doi.org/10.1155/2014/109378 |
work_keys_str_mv |
AT andrewcook hipresurfacingarthroplastyandperioperativebloodtesting AT stevencook hipresurfacingarthroplastyandperioperativebloodtesting AT iansmith hipresurfacingarthroplastyandperioperativebloodtesting AT patrickweinrauch hipresurfacingarthroplastyandperioperativebloodtesting |
_version_ |
1725818947390930944 |